Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Tianhao Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company maintains a strong focus on chronic disease management, particularly in the fields of metabolic disorders and cardiovascular health. Operating out of the Hangzhou Gulf Fine Chemical Zone, the company adheres to international GMP standards to supply both domestic and global markets. Its commercial portfolio is anchored by widely used generic medications, including metformin and various antihypertensive agents. Zhejiang Tianhao Pharmaceutical is recognized for its integrated production capabilities, spanning from chemical synthesis to final packaging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Tianhao Pharmaceutical.